We are live on !
Find out more
Mariner Portfolio holdings
AUM
$95.2B
Turnover
23.58%
1-Year Est. Return
32.92%
This Fund
S&P 500
This Quarter Est. Return
+19.43%
1 Year Est. Return
+32.92%
3 Year Est. Return
+93.86%
5 Year Est. Return
+109.77%
10 Year Est. Return
+319.92%
AUM
$95.2B
AUM Growth
+$9.5B
(+11%)
Cap. Flow
-$1.86B
Cap. Flow % of AUM
Cap. Flow %
-1.95%
Top 10 Holdings %
Top 10 Hldgs %
27.89%
Holding
4,003
New
458
Increased
1,438
Reduced
1,530
Closed
486
Avg Time Held
3.2
years
Top 10 Avg Time Held
4.4
years
Top 20 Avg Time Held
5.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$318M |
| 2 |
Jazz Pharmaceuticals
JAZZ
|
+$125M |
| 3 |
TJX Companies
TJX
|
+$120M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$110M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$105M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ProShares Ultra Semiconductors
USD
|
+$318M |
| 2 |
Home Depot
HD
|
+$139M |
| 3 |
Microsoft
MSFT
|
+$129M |
| 4 |
Corning
GLW
|
+$126M |
| 5 |
iShares Russell Top 200 Growth ETF
IWY
|
+$113M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 40.96% |
| 2 | Technology | 24.61% |
| 3 | Financials | 7.71% |
| 4 | Healthcare | 5.25% |
| 5 | Industrials | 5.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3351
Western Asset High Income Opportunity Fund
HIO
$306M
| $86.7K | ﹤0.01% |
23,824
-4,013
| -14% | -$14.6K |
2023 Q3
11 quarters
|
|
3352
Galectin Therapeutics
GALT
$322M
| $85.8K | ﹤0.01% |
18,500
-1,312
| -7% | -$3.4K |
2022 Q3
15 quarters
|
|
3353
AerSale
ASLE
$223M
| $85.6K | ﹤0.01% |
+13,539
| New | +$88.5K |
2026 Q2
0 quarters
|
|
3354
Denison Mines
DNN
$1.96B
| $85K | ﹤0.01% |
27,771
+1,250
| +5% | +$4.36K |
2022 Q3
15 quarters
|
|
3355
TPG Mortgage Investment Trust
MITT
$173M
| $84.8K | ﹤0.01% |
+10,707
| New | +$83.6K |
2026 Q2
0 quarters
|
|
3356
Ballard Power Systems
BLDP
$516M
| $84.4K | ﹤0.01% |
21,707
-1,099
| -5% | -$4.48K |
2022 Q3
15 quarters
|
|
3357
CION Investment
CION
$319M
| $81.7K | ﹤0.01% |
13,115
-663
| -5% | -$4.63K |
2021 Q4
18 quarters
|
|
3358
Avita Medical
RCEL
$480M
| $81.1K | ﹤0.01% |
+19,634
| New | +$84.7K |
2026 Q2
0 quarters
|
|
3359
Serve Robotics
SERV
$241M
| $80.7K | ﹤0.01% |
+12,268
| New | +$102K |
2026 Q2
0 quarters
|
|
3360
Portillo's
PTLO
$305M
| $80.1K | ﹤0.01% |
16,900
+4,432
| +36% | +$21.5K |
2025 Q4
2 quarters
|
|
3361
SS Innovations International
SSII
$451M
| $79.7K | ﹤0.01% |
19,211
+554
| +3% | +$2.25K |
2025 Q2
4 quarters
|
|
3362
Proficient Auto Logistics
PAL
$76M
| $78.1K | ﹤0.01% |
11,467
+9
| +0.1% | +$60 |
2026 Q1
1 quarter
|
|
|
DHY
3363
UBS Asset Management High Yield Credit Fund
DHY
$222M
| $77.2K | ﹤0.01% |
4,339
+1,000
| +30% | +$17.8K |
2025 Q1
5 quarters
|
|
3364
Douglas Elliman
DOUG
$145M
| $76.5K | ﹤0.01% |
43,244
+30,050
| +228% | +$53.9K |
2026 Q1
1 quarter
|
|
3365
Niagen Bioscience
NAGE
$192M
| $75.9K | ﹤0.01% |
23,773
-25,225
| -51% | -$102K |
2025 Q2
4 quarters
|
|
3366
Opko Health
OPK
$1.22B
| $75.7K | ﹤0.01% |
50,486
+11,140
| +28% | +$14.2K |
2025 Q1
5 quarters
|
|
3367
Standard BioTools
LAB
$239M
| $75.3K | ﹤0.01% |
91,537
+44,380
| +94% | +$41.9K |
2025 Q1
5 quarters
|
|
3368
Hain Celestial
HAIN
$13.7M
| $75K | ﹤0.01% |
133,872
+86,469
| +182% | +$64.2K |
2025 Q2
4 quarters
|
|
3369
eHealth
EHTH
$17M
| $74.7K | ﹤0.01% |
50,180
+18,669
| +59% | +$31.3K |
2026 Q1
1 quarter
|
|
3370
Coherus Oncology
CHRS
$156M
| $73K | ﹤0.01% |
52,167
+25,428
| +95% | +$41.5K |
2025 Q4
2 quarters
|
|
3371
Lifezone Metals
LZM
$312M
| $72K | ﹤0.01% |
+18,549
| New | +$86.6K |
2026 Q2
0 quarters
|
|
3372
BNY Mellon Strategic Municipal Bond Fund
DSM
$262M
| $71.8K | ﹤0.01% |
11,676
+85
| +0.7% | +$517 |
2023 Q4
10 quarters
|
|
3373
Organigram Holdings
OGI
$134M
| $71.6K | ﹤0.01% |
70,173
-1,805
| -3% | -$2.2K |
2025 Q1
5 quarters
|
|
|
UROY
3374
Uranium Royalty Corp
UROY
$1.31B
| $70K | ﹤0.01% |
+25,183
| New | +$88.3K |
2026 Q2
0 quarters
|
|
3375
Horizon Technology Finance
HRZN
$265M
| $69.8K | ﹤0.01% |
+14,760
| New | +$63.8K |
2026 Q2
0 quarters
|
|
Similar funds
Mariner's Q2 2026 Portfolio in Review
As of Q2 2026, Mariner held 4,003 positions worth $95.2B, up 11% from $85.7B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Mariner's Q2 2026 filing shows 458 new, 1,438 increased, 1,530 reduced and 486 closed positions. Its largest new stake was Honeywell Aerospace: 217,569 shares worth $48.1M. The largest sale was ProShares Ultra Semiconductors, an estimated $318M.
By sector, the portfolio is most concentrated in Miscellaneous at 41% of assets, down from 43% a quarter earlier, followed by Technology and Financials.
- Mariner's largest Q2 2026 buy was Honeywell Aerospace: 217,569 shares worth $48.1M.
- Mariner added most to Micron Technology in Q2 2026, an estimated $318M increase.
- Mariner's biggest Q2 2026 reduction was ProShares Ultra Semiconductors, cutting an estimated $318M.
- Mariner fully exited Fidelity Fundamental Large Cap Core ETF in Q2 2026, selling an estimated $52.7M.
- Mariner's ten largest holdings make up 28% of its $95.2B portfolio in Q2 2026.
- Mariner opened 458 new positions and closed 486 in Q2 2026.
- Mariner's portfolio value rose 11% quarter-over-quarter to $95.2B.
Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.